For investors
Built. Patent-protected.*
Choosing partners.
Alpenglow — the personal-sovereignty AI platform — is one product. The technology underneath it is the asset, with patent-pending applications across a portfolio of vertical deployments: financial infrastructure, secure data storage, healthcare screening, defense systems, on-device intelligence, and more. The capital deployment looks unlike traditional venture. The partner selection is more selective than the funding. Read on if that's the kind of conversation you want to be in.
What this actually is
The platform is one surface. The technology is the asset.
The substrate underneath Alpenglow is a stack of proprietary, patent-pending primitives. Memory architecture. Federated learning. Substrate-native inference. Storage and security model. Constitutional warrant gate. A number of additional claims that are not described publicly. Each primitive has direct application in verticals well beyond the consumer agent platform.
Examples — at the category level, without disclosing the deployment roadmap:
- Financial settlement infrastructure that replaces multi-day reconciliation pipelines with deterministic clearing measured in bytes on the wire.
- Defense-grade data storage that is structurally unrecognizable to commodity forensic tools — not because of stronger encryption, but because of a different storage model entirely.
- Secure communications without certificate authorities, key escrow, or central trust points.
- Healthcare screening applications that operate over federated, anonymized signal rather than centralized data aggregation.
- On-device frontier inference with cost economics that GPU-cluster providers cannot match.
These are not research projects. The underlying technology is built and tested. Vertical deployment is integration work, not invention work. The timeline from serious engagement to first deployment in any given vertical is measured in months, not years.
How we think about capital
Not a research hole. Not a unicorn race. Not a check-cashing exercise.
A research-stage bet.
The fundamental technology works. We're not asking capital to fund a maybe. The provisional patents are filed; the verticals are mapped; the deployment work is integration, not invention.
An IP-acquisition opportunity.
The IP holding company is not for sale. The substrate IP will live in a trust structured to preserve the founder's mission and operating principles. That structure is non-negotiable. If your mandate requires acquiring the underlying technology or controlling the IP, this is the wrong conversation.
A check-cashing exercise.
Capital alone is not what gets the technology to deployment. The right partner brings network — real relationships in the verticals where the technology lands (banks, regulators, defense procurement, healthcare systems, telecom, energy, where applicable to your reach) — and the willingness to make warm introductions to operators we can sign with.
Engagement protocol
Direct, in person, NDA-first.
We listen to anyone. Selection is a separate matter, and is not a function of check size. Three rules govern the conversation:
NDA before the conversation, not after.
We do not pitch the technology in exploratory meetings. When there is something substantive to discuss, an NDA is in place beforehand. The capability is the public claim; the implementation is not.
In person, not phone, not email.
Substantive conversations happen face-to-face. We will travel where warranted. We will not take capital from a partner whose hand we have not shaken and whose eyes we have not looked into. That is not ceremony — it is judgment about who we choose to build a 20-year relationship with.
The IP holding company is not for sale.
Stated again because it gets asked. Equity in deployment entities is on the table. The substrate IP itself, and the holding company that owns it, are not. The IP will live in a trust to preserve mission and principles beyond the founder's tenure. Don't ask for an exception; there isn't one.
Capital efficiency, in plain terms
Zero dollars wasted on the way to revenue.
Most early-stage capital is spent before any of it produces revenue. That is the dynamic this structure does not have.
- No cloud-services bill. The architecture is intentionally not cloud-resident at the substrate layer; we don't have a recurring infrastructure cost that scales with usage.
- No corporate office. No ping-pong table. No smoothie bar. No real estate as a sunk cost.
- No headcount bloat. The team is small by design and stays small until a specific deployment partnership warrants specialist headcount in a specific vertical.
- No founder salary. The inventor takes nothing until everyone else who has joined is at least at subsistence-level compensation.
- No marketing pyrotechnics. The website you're reading is the marketing budget.
Personal guarantee from the founder: zero dollars will be wasted on the way to revenue. A small amount of well-deployed capital does meaningful work in this structure — not because we're aggressively cost-cutting, but because the technology is built before the capital is asked for, not after.
Minimum consideration
$2M floor. Single check or aggregated cohort.
The minimum for serious consideration is two million dollars. Single investor or aggregated cohort — we don't care about the structure of the contribution. We care that you've decided to engage at a level commensurate with the scope.
What does matter: the individuals.
Cohort structure doesn't bypass the individual filter. Every investor — whether you're writing the whole check yourself, you're one of twenty angels in an aggregated cohort, or you're an LP in a fund that's participating — gets met in person and background-checked. The founder runs that vet personally. We reserve the right to deny investor access to any individual, regardless of how they arrived at the conversation and regardless of what the rest of the cohort looks like. The people involved matter more than the money — by a wide margin.
We are deliberately not publishing a valuation number on this page. As a frame of reference: comparable companies in the agent-platform category — companies that have built a fraction of what's described elsewhere on this site, and are operating without the underlying primitives we have — have been acquired in the high-nine-figure range and carry billion-dollar valuations on the private market. Recent acquisitions in the adjacent AI-memory category have closed in the multi-hundred-million-dollar range for products that don't yet have working systems shipping to users. The platform described on this website, pre-launch, fits naturally in that conversation. The technology stack underneath the platform is in a different conversation entirely.
The number that fits the IP, deployed across the vertical portfolio, is large enough that quoting it on a public page would make us look unserious. We're not going to. Investors whose internal models can size this independently are the conversation we're looking for. Bring your own valuation framework — we won't anchor it for you, and we'd rather know what you arrived at on your own.
If this is the conversation you want
NDA. Meeting. Conversation.
One email to investors@alpenglowagents.com. Three things in it:
- Who you are. The fund or firm you represent (or that you're an angel acting independently). Decision authority on a check, or stage in your process.
- What network you bring beyond capital. Verticals, geographies, named or unnamed introductions you can make to deployment partners. The check size matters less than the network behind it.
- Confirmation that you've read this page and understand the engagement protocol — NDA-first, in-person, IP-not-for-sale.
If we proceed, the next step is an NDA, then an in-person meeting. If we don't, you'll get a one-line reply telling you so. Don't reach out if you aren't serious. Sign the NDA. Be prepared to have what you thought you knew about this space substantially rearranged.